Somewhat striking was the finding that only a small number of ME/CFS cases’ sera (n = 14; 3.77%) exhibited increased CXCL13 levels above baseline despite the presence of high levels of IL-21. This evidence concerns the gene CXCL13 and myalgic encephalomeyelitis/chronic fatigue syndrome.